Medici Ventures takes stake in Symbiont

SALT LAKE CITY, July 19, 2017 (GLOBE NEWSWIRE) — Medici Ventures and Symbiont today announced the completion of a strategic investment in Symbiont by Medici Ventures, a major investor in blockchain technology. As part of the new relationship, the two companies will collaborate on strategic projects involving both Medici Ventures and its parent company, Common Shares (NASDAQ:OSTK) / Series A Preferred (Medici Ventures’ t0 platform : OSTKP) / Series B Preferred (OTCQX:OSTBP).

For the full press release, click here.

Related Posts

Previous Post
Fidelity and Goldman Sachs partner for non-purpose loans
Next Post
Clearstream releases business overview, readies for CSD-regulation

Fill out this field
Fill out this field
Please enter a valid email address.


Reset password

Create an account